# Codex Review: medical_monitoring_project_neutral_literal_guard_20260806

Date: 2026-08-06 (Asia/Shanghai)
Route: direct Codex (`hermes/codex/codex-main:high`); no delegated agent or external model was dispatched.

## Verdict

PASS — static project-neutral/path-neutral negative contract only. This is not evidence of three-project generalization or clinical acceptance.

## Boundary Check

- The only product-tree change is the feature-owned test `frontend/src/features/medical-monitoring/medicalMonitoringProjectNeutralContract.test.mjs`.
- The guard recursively scans production `.mjs/.jsx/.css` files and excludes `*.test.*`, so its adversarial literals do not create false findings.
- No `App.jsx`, `styles.css`, `main.jsx`, medical-writing source, backend/API/schema/database, source registry, provider, browser, runtime, real-project or release file was changed.
- The guard does not scan or copy any real study data and grants no runtime, medical, authorization or organization-approval authority.

## Codex Verification

- Project-neutral guard: PASS — 66 production files scanned; adversarial known-project/company/path literals are rejected by the patterns.
- Full Node suite: PASS — 44 subtests / 0 failures, including 38 medical-monitoring feature contracts and existing medical-writing/writing-reference tests.
- Focused Python monitoring/timeline contracts: PASS — 74 passed.
- Vite build: PASS — 1,956 modules transformed; existing >500 kB chunk advisory remains.
- Protected shell hashes: App `de942af37999e708d124c99e1beb47fcd2c405ff23ed83fee6dbcc4cf5e0beed`; styles `dbd1a99c31cb4877c7f9b13dc8dee7804a39d20a3c0ee805eb4b4a70a76bcefd`; main `869dbab992b086a2c38ae8ab1d44ca9b7d0014ef4614b85a5154bc3fcebc8f05`.
- Listener check: no listeners on 8911, 5174, 8910 or 4173.
- The current real-loop gate remains `read_only / blocked`; no service/provider/browser/Playwright/API-login/real-project/SQLite/CAS/B6/C14/source-token/P8/Safety-PV action was run.

## Interpretation

The contract is a preventive source-level check against embedding known project/company names or local file locations in feature-owned production frontend code. Passing proves only that the current source contains none of the enumerated literals; it cannot establish schema adaptability, source extraction correctness, clinical/scientific validity, UI usability, model independence or generalization across MG-K10-SAR, Ruxolitinib-AD and MY008/MY009 projects.

## Residual Risk

The literal list is intentionally finite and cannot detect every form of semantic overfitting. Real raw-file three-project LOOP, browser visual/scientific review, formal medical review, P8 evidence authority, B6/C14, independent AI evidence and commercial release remain unverified or blocked. Keep 8911 and all runtime ports stopped.
